Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations
Journal of Diabetes and its Complications, 08/21/09
Marfella R et al. – The authors data suggest that dipeptidyl peptidase IV inhibition therapy should target not only reducing HbA1c but also flattening acute glucose fluctuations over a daily period.
Related Articles
Glucose Regulation in Acute Stroke Patients (GRASP) Trial. A Randomized Pilot Trial
Stroke, 10/27/09
Relevance Score: 67%
Acute altitude-induced hypoxia suppresses plasma glucose and leptin in healthy humans
Metabolism-Clinical and Experimental, 10/09/09
Relevance Score: 67%
Oral nitrate therapy does not affect glucose metabolism in healthy men
Clinical and Experimental Pharmacology and Physiology, 11/13/09
Relevance Score: 66%
Acute insulin resistance following injury
Trends in Endocrinology and Metabolism, 10/19/09
Relevance Score: 66%
Phosphatidyl Inositol 3-Kinase Signaling in Hypothalamic Proopiomelanocortin Neurons Contributes to the Regulation of Glucose Homeostasis
Endocrinology, 10/15/09
Relevance Score: 66%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09
Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/18/09
Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women
Women's Health, 12/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Temozolomide (Temodar) and capecitabine (Xeloda) treatment of an aggressive corticotroph pituitary tumor
Pituitary, 12/18/09
New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


